Grade 3/4 dermatitis in head and neck cancer patients treated with concurrent cetuximab and IMRT.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  International Journal of Radiation Oncology, Biology, Physics

• Publication date

  2011-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ijrobp.2010.05.018PMID 20732757
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival.

  2010cited by this paper
• Concomitant chemoradiation versus radical radiotherapy in advanced squamous cell carcinoma of oropharynx and nasopharynx using weekly cisplatin: a phase II randomized trial.

  2010cited by this paper
• High rate of severe radiation dermatitis during radiation therapy with concurrent cetuximab in head and neck cancer: results of a survey in EORTC institutes.

  2009cited by this paper
• Enhanced toxicity with concurrent cetuximab and radiotherapy in head and neck cancer.

  2009cited by this paper
• Severe Radiation Dermatitis in Patients With Locally Advanced Head and Neck Cancer Treated With Concurrent Radiation and Cetuximab

  2009cited by this paper
• Cetuximab is effective, but more toxic than reported in the Bonner trial.

  2008cited by this paper
• Severe skin reaction secondary to concomitant radiotherapy plus cetuximab

  2008cited by this paper
• Consensus guidelines for the management of radiation dermatitis and coexisting acne-like rash in patients receiving radiotherapy plus EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck.

  2008cited by this paper
• Severe cutaneous reaction during radiation therapy with concurrent cetuximab.

  2007cited by this paper
• Acneiform rash secondary to cetuximab plus head and neck radiotherapy.

  2007cited by this paper
• Quality of life in head and neck cancer patients after treatment with high-dose radiotherapy alone or in combination with cetuximab.

  2007cited by this paper
• Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: a pilot phase II study of a new combined-modality paradigm.

  2006cited by this paper
• Determining optimal clinical target volume margins in head-and-neck cancer based on microscopic extracapsular extension of metastatic neck nodes.

  2006cited by this paper
• IMRT using simultaneously integrated boost (SIB) in head and neck cancer patients

  2006cited by this paper
• Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck.

  2006cited by this paper
• Phase III randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic/recurrent head and neck cancer: an Eastern Cooperative Oncology Group study.

  2005cited by this paper
• Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapy.

  2004cited by this paper
• Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study.

  2004cited by this paper
• Determination and delineation of nodal target volumes for head-and-neck cancer based on patterns of failure in patients receiving definitive and postoperative IMRT.

  2002cited by this paper
• Phase I study of anti--epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancer.

  2001cited by this paper
• Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.

  1999cited by this paper
• Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma.

  1999cited by this paper
• Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck: a prospective randomized trial.

  1997cited by this paper

• Dose–toxicity surface histogram-based prediction of radiation dermatitis severity and shape

  2024influential citation
• Correlation of degree of acute radiation dermatitis (RD) with skin dose distribution in head and neck squamous cell carcinoma patients treated with definitive concurrent chemoradiation

  2024cites this paper
• Topical Phenytoin Versus Placebo in the Management of Acute Radiation-Induced Dermatitis in Patients with Breast Cancer: A Double-Blind Randomized Controlled Trial

  2023cites this paper
• Effect of topical agents on skin surface dose in volumetric modulated arc therapy for head and neck cancer

  2023cites this paper
• Efficacy of Supportive Care for Radiodermatitis in Patients with Head and Neck Cancer: Supplementary Analysis of an Exploratory Phase II Trial

  2023cites this paper
• A novel approach to predict acute radiation dermatitis in patients with head and neck cancer using a model based on Bayesian probability.

  2023cites this paper
• A pilot study of a novel method to visualize three-dimensional dose distribution on skin surface images to evaluate radiation dermatitis

  2022cites this paper
• Phase 3 randomized trial of topical steroid versus placebo for prevention of radiation dermatitis in head and neck cancer patients receiving chemoradiation.

  2021cites this paper
• Analysis of skin dose distribution for the prediction of severe radiation dermatitis in head and neck squamous cell carcinoma patients treated with concurrent chemo‐radiotherapy

  2020cites this paper
• How Should We Approach Locally Advanced Squamous Cell Carcinoma of Head and Neck Cancer Patients Ineligible for Standard Non-surgical Treatment?

  2020cites this paper
• The incidence and risk factors of acute radiation-induced dermatitis in gynecologic malignancies treated with intensity-modulated radiation therapy

  2020cites this paper
• Reply to Yamazaki et al (HED‐19‐525.R1)

  2020cites this paper
• Safety and efficacy of concurrent carboplatin or cetuximab plus radiotherapy for locally advanced head and neck cancer patients ineligible for treatment with cisplatin

  2019cites this paper
• Monitoring skin dose changes during image-guided helical tomotherapy for head and neck cancer patients

  2019cites this paper
• Use of trolamine to prevent and treat acute radiation dermatitis: a systematic review and meta-analysis

  2018cites this paper
• Skin DVHs predict cutaneous toxicity in Head and Neck Cancer patients treated with Tomotherapy.

  2018cites this paper
• Incidence of skin toxicity in squamous cell carcinoma of the head and neck treated with radiotherapy and cetuximab: A systematic review.

  2017cites this paper
• Head and Neck Radiation Therapy Sequelae and Late Complications and the Role of IMRT

  2017cites this paper
• Multicenter Randomized Double-Blind, Placebo-Controlled Trial GORTEC (Groupe Oncologie Radiotherapie Tete et Cou) 2009-01 Evaluating the Effect of the Regenerating Agent on Radiodermatitis of Head and Neck Cancer Patients.

  2017cites this paper
• IMRT for head and neck cancer: reducing xerostomia and dysphagia

  2016cites this paper
• Enhanced radiation dermatitis associated with concurrent palliative radiation and vemurafenib therapy.

  2016cites this paper
• Real-life assessment of Volumetric Modulated Arc Therapy (VMAT) toxicity in Head and Neck Squamous Cell Carcinoma (HNSCC) treatment

  2016cites this paper
• Toxicity of concomitant cetuximab and radiotherapy with or without initial taxane‐based induction chemotherapy in locally advanced head and neck cancer

  2016cites this paper
• Comparison between Chemoradiotherapy and Bioradiotherapy after induction chemotherapy in head and neck cancer

  2016cites this paper
• Initial experience of radiotherapy plus cetuximab for Japanese head and neck cancer patients

  2015cites this paper
• Safety and efficacy of concurrent carboplatin plus radiotherapy for locally advanced head and neck cancer patients ineligible for treatment with cisplatin.

  2015cites this paper
• Drugs that act on the immune system: cytokines and monoclonal antibodies

  2014cites this paper
• TPF induction chemotherapy and concomitant irradiation with cisplatin and cetuximab in unresectable squamous cell carcinoma of the head and neck

  2014cites this paper
• Severe gastrointestinal bleeding in patients with locally advanced head and neck squamous cell carcinoma treated by concurrent radiotherapy and Cetuximab

  2014cites this paper
• Mometasone furoate cream reduces acute radiation dermatitis in patients receiving breast radiation therapy: results of a randomized trial.

  2014cites this paper
• RADIATION & YOUR PATIENT

  2014cites this paper
• Acute and Chronic Cutaneous Reactions to Radiotherapy

  2013cites this paper
• Monoclonal Antibodies in Cancer

  2013cites this paper
• Management of ‘In-Field' Skin Toxicity in Head and Neck Cancer Patients Treated with Combined Cetuximab and Radiotherapy

  2013cites this paper
• Cetuximab: its unique place in head and neck cancer treatment

  2013cites this paper
• Late term tolerance in head neck cancer patients irradiated in the IMRT era

  2013cites this paper
• The effects on pain and activity of daily living caused by crusted exudation in patients with head and neck cancer treated with cetuximab and radiotherapy

  2012cites this paper
• Neck node bolus technique in the treatment of Nasopharyngeal Carcinoma with Intensity-modulated radiotherapy.

  2012cites this paper
• Cetuximab-related radiation dermatitis in head-and-neck cancer patients: in regard to Studer et al. (Int J Radiat Oncol Biol Phys in press).

  2011cites this paper
• Drugs that act on the immune system

  2011cites this paper
• Distinct patterns of stomatitis with concurrent cetuximab and radiotherapy for head and neck squamous cell carcinoma.

  2011cites this paper
• The emerging era of personalized therapy in squamous cell carcinoma of the head and neck

  2011cites this paper
• Prospective phase II trial of cetuximab plus VMAT-SIB in locally advanced head and neck squamous cell carcinoma

  2011cites this paper
• Radiotherapy and "new" drugs-new side effects?

  2011cites this paper
• Grading system and management guidelines for dermatitis induced by head and neck radiotherapy plus cetuximab: clinical validation required.

  2011cites this paper
• Organ-sparing radiation therapy for head and neck cancer

  2011cites this paper
• Cetuximab in the treatment of squamous cell carcinoma of the head and neck

  2011cites this paper